Free Trial

Armis Advisers LLC Makes New Investment in Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

Armis Advisers LLC purchased a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,356 shares of the company's stock, valued at approximately $295,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ADUS. Capital Research Global Investors acquired a new position in Addus HomeCare in the 4th quarter valued at about $51,149,000. American Century Companies Inc. raised its stake in Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock valued at $35,643,000 after purchasing an additional 248,613 shares during the last quarter. Bank of America Corp DE raised its stake in Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after purchasing an additional 128,211 shares during the last quarter. TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after purchasing an additional 78,835 shares during the last quarter. Finally, Pier Capital LLC acquired a new position in Addus HomeCare in the 4th quarter valued at about $8,406,000. Institutional investors and hedge funds own 95.35% of the company's stock.

Wall Street Analyst Weigh In

ADUS has been the subject of several analyst reports. Stephens reissued an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie boosted their target price on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. JMP Securities reissued a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $142.57.

Read Our Latest Research Report on Addus HomeCare

Insider Transactions at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares in the company, valued at approximately $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 4.60% of the company's stock.

Addus HomeCare Trading Down 0.7%

ADUS traded down $0.82 during midday trading on Friday, hitting $112.31. The company's stock had a trading volume of 238,885 shares, compared to its average volume of 169,127. The firm has a market cap of $2.07 billion, a P/E ratio of 25.70, a PEG ratio of 1.41 and a beta of 0.85. The firm has a 50-day moving average price of $104.45 and a two-hundred day moving average price of $112.73. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. During the same quarter in the previous year, the business earned $1.21 EPS. The company's revenue for the quarter was up 20.3% on a year-over-year basis. On average, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?
These 3 Penny Stocks Could Surprise Everyone This Summer!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines